Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia — Stella

Home/Androgenetic Alopecia (AGA)/

View on ClinicalTrials.gov

Recruiting

Back to Androgenetic Alopecia (AGA) trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

Zhongshan Hospital Fudan University, Shanghai, Shanghai Municipality

Key details

Phase

Very early testing

Sponsor

Shanghai Zhongshan Hospital

Enrollment target

~30 participants

Started

June 2025

Primary completion

May 2026

Age range

18 Years – 40 Years

Sex

Female only

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Last updated June 2025